Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis

scientific article published on January 2013

Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.ATHEROSCLEROSISSUP.2012.10.030
P698PubMed publication ID23357165

P50authorGerhard OpelzQ74988199
P2093author name stringMartin Zeier
Peter Schemmer
Christian Morath
Vedat Schwenger
Sabine Scherer
Jörg Beimler
Stephan Macher-Goeppinger
Caner Süsal
Katrin Klein
Luis Eduardo Becker
Sebastian M Schäfer
P433issue1
P304page(s)199-202
P577publication date2013-01-01
P1433published inAtherosclerosis. SupplementsQ27714892
P1476titleLiving donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis
P478volume14

Reverse relations

cites work (P2860)
Q35677259Antigen-Specific versus Non-Antigen-Specific Immunoadsorption in ABO-Incompatible Renal Transplantation
Q38265563Clinical relevance of HLA antibody monitoring after kidney transplantation
Q26863564Desensitization for solid organ and hematopoietic stem cell transplantation
Q95654173One-Year Outcomes of Living Related Kidney Transplant in Patients With Preformed HLA Donor-Specific Antibodies: A Single-Center Experience in Malaysia
Q35885244Outcome after Desensitization in HLA or ABO-Incompatible Kidney Transplant Recipients: A Single Center Experience.
Q44753304Quantifying the risk of incompatible kidney transplantation: a multicenter study.
Q26767324Rabbit antithymocyte globulin and donor-specific antibodies in kidney transplantation--A review
Q40503602Successful Transplantation in ABO- and HLA-Incompatible Living Kidney Transplant Patients: A Report on 12 Cases

Search more.